
About Acologix
Acologix is a Healthcare company based in Hayward (United States) founded in 1992. Therapeutics are developed for kidney and bone metabolic disorders. Acologix has raised $69.8 million across 2 funding rounds from investors including Tokio Marine Holdings, Nomura and SoftBank. The company has 13 employees. Its focus areas include Life Sciences, Dental Disorders and Drugs. Its legal entity is ACOLOGIX, INC. Its competitors include Marizyme, OraPharma and IntraBiotics Pharmaceuticals; 2 of its 3 listed competitors have raised funding.
Company details
Acologix was founded in 1992 and is based in Hayward, United States. Therapeutics are developed by the company for metabolic disorders affecting kidney and bone functions. Research is focused on mineral metabolism and extracellular matrix molecules that support bone and connective tissue. AC-100 (Dentonin) is being advanced for periodontal defect repair and dental restorations. Phosphatonin is under development to address hyperphosphatemia and related issues in chronic kidney disease patients.
- Headquarters Hayward, United States
- Employees 13
- SectorsHealthcare
- Website acologix.com
- Legal Name Acologix, Inc.
- Total Equity Funding$69.8M (USD)
in 2 rounds
- Latest Funding Round$29.8M (USD), Series C
Feb 2006
- InvestorsTokio Marine Holdings
& 4 more
- Employee Count13
Funding Insights of Acologix
Acologix has successfully raised a total of $69.8M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $29.8 million completed in February 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $69.8M
- Total Rounds 2
- Last Round Series C β $29.8M
- First Round $40M
(May 2004)
- Investors Count 5
All 2 funding rounds of Acologix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2006 | $29.8M | Series C | β | β | β |
| May 2004 | $40M | Series B | β | β |
5 investors in total: 5 institutional.
Investors in Acologix
Acologix has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Tokio Marine Holdings, Nomura and SoftBank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| smbc-vc.co.jp | ||||
PE and VC fund focused on fintech, Adtech, gaming, eCommerce, and multiple sectors | softbank.com | Newton, United States | ||
Diversified asset management services are offered globally by the firm. | 1925 | nomura.com | Chuo City, Japan | |
| jaicamerica.com | ||||
Provider of non-life insurance services | 2002 | tokiomarinehd.com | Chiyoda City, Japan |
Investor details for Acologix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Acologix
3 dated milestones of Acologix across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Acologix is founded.
- Funding First funding round of $40.0M.
- Funding Latest funding round, Series C, of $29.8M.
Competitors of Acologix
Acologix has 3 listed competitors in our database, 2 of them funded. They include Marizyme, OraPharma and IntraBiotics Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| marizyme.com | 2007 | Woodstock, United States | 11 | Therapies for chronic wounds, thrombolysis, and dental health are developed. | ||
| orapharma.com | 1997 | Bridgewater, United States | $16M | Oral health products for treatment and maintenance are developed. | ||
| intrabiotics.com | 1994 | Mountain View, United States | $40.4M | Antibiotics for oral mucositis in head-and-neck cancer patients are developed. |
Detailed competitors of Acologix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dental Disorders
3 companies that operate in the same segment as Acologix (Dental Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Custom 3D printed dental aligners are developed for teeth straightening. | 2017 | New York, New York, United States | USD 147.78 M | |||
Invisalign clear aligners and dental products are developed. | 1997 | Tempe, Arizona, United States | USD 101 M | 1,051 | ||
Optical equipment for micron-level surface geometry capture is offered. | 2011 | Waltham, Massachusetts, United States | USD 16.22 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acologix
Complete news archive for Acologix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acologix
Acologix was founded in 1992 and raised its 1st funding round 12 years after it was founded.
Acologix is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Acologix is a funded company, having raised a total of $69.8M across 2 funding rounds to date. The company's 1st funding round was a Series B of $40M, raised on May 2004.
Acologix has 13 employees.
Acologix was founded in 1992 and is based in Hayward, United States. Therapeutics are developed by the company for metabolic disorders affecting kidney and bone functions. Research is focused on mineral metabolism and extracellular matrix molecules that support bone and connective tissue. AC-100 (Dentonin) is being advanced for periodontal defect repair and dental restorations. Phosphatonin is under development to address hyperphosphatemia and related issues in chronic kidney disease patients.
Acologix's top competitors include Marizyme, OraPharma and IntraBiotics Pharmaceuticals.
Acologix has 5 investors. Key investors include Tokio Marine Holdings, Nomura, SoftBank, SMBC Venture Capital, and JAIC America.
Acologix operates through Acologix, Inc..
